Akaki Zoidze, head of parliament committee for health and social issues:
We carried out very important reforms in health system in 2017, first of all, we have introduced the model adjusted to the existing needs, when the rich part of our society has limited access to universal health program benefits. In turn, this package was broadened to socially vulnerable citizens. Namely, on September 1 Government launched the program for supply of medications to patients with chronic illness. This is huge relief for the poor, who have four chronic disorders – arterial tension or diabetics (insulin-dependent or insulin-excluding diseases), thyroid gland disease, asthma … these diseases are widespread and a major part of similar patients are poor. They need expensive medications every day and their prices rise following the GEL exchange rate changes. The program will be continued in 2018 too and the poor will be able to save a half part of their pensions.
We will move to the so-called selective contracting mechanism and this implies a selection of the facility, which will provide better quality and qualified services. Consequently, only these facilities will remain in universal health program. Medical facilities will have enough time to satisfy the due standards. If they fail to do so, they will not be able to participate in the universal health program and their contract agreements will not be continued.
The works for introducing digital prescriptions is of crucial importance. Restoration of the institute of prescriptions was a right decision. It was expedient to establish the digital system immediately, because paper carriers cannot fully reflect the real situation and ensure valuable analysis. And this system enables to cast light on details related to prescription of extra medications (how, whom, where). Divulging these results will ensure rational use of medications. The current practice is unacceptable – frequently patients need one medication, but doctors prescribe 5-6 medications, because some doctors have business interests in certain pharmaceutical companies.
Program for chronic disorders is also very important. The issue is of about 700 000 persons with 0-100 000 scores (100-150 thousand persons have chronic disorders). In the future we plan to direct existing reserves to expansion of coverage and contingent in this direction, expansion of the list of medications. We plan to introduce this system in 2018, if we fail to do so in 2018, this system will be established definitely in 2019-2020.
The medications project will enable to enhance primary health role. Primary health system is the backbone of primary health system, where we should resolve, treat and manage 80% of the health problems without hospitals and expensive interventions. We can achieve this through healthy lifestyle, primary health services, prevention mechanisms and we will make accent on this direction in the coming years.
Jointly with the Ministry, we have prepared a long-term vision through involvement of wide society and determined the target direction up to 2030 in the direction of social, labor relations, healthcare issues. Our action plans will be based on these directions.
We have improved immunization program, programs for mothers and children. This signifies a referral program will be launched that has reduced death toll. This is a huge achievement.
I would also name the parliament-performed job for public health issues and adoption of tobacco control law.
Excluding rare exceptions, everywhere in the world the health market is regulated in this or that form. This is an asymmetric market, where supply determines the demand, not on the contrary. There are many other problems – all these factors substantiate state involvement in the market, including in terms of medical services, price regulations, including in terms of regulation of medication prices. We do not regulate prices. Only the God knows on what principle it depends. They do not know themselves how much the supplied service costs. All prices are conditional and depend on individual preferences. We have access to global experience. It is important to introduce just pricing depending on resource capacity. Introduction of this principle will take a certain time, because big volumes of statistical indicators should be processed, many people should be trained.
This system should be established in not only state health system, but, in general, and in this case prices will be identical and transparent for private insurance companies and individual patients. At this stage, tariffs are determined only in universal health system and this approach will be general for everybody. For example, we can refer to the sample of Germany, where prices are revised every three years.
As to medical business, it genuinely flourishes today. Commercial banks issue loans for expansion of medical business or other needs without problems. In 2.5 years 57 clinics opened in the country. Similar paces in development, excessive commercialization grows expenditures and enables to supply excessive services that may be unnecessary for patients. I believe this sector should be regulated to a certain extent.